Leerink Partnrs Has Strong Forecast for UHS Q3 Earnings

Key Points

• Leerink Partners has raised its Q3 2025 earnings estimate for Universal Health Services (UHS) to $4.88 per share, up from a previous estimate of $4.17.
• UHS reported a quarterly EPS of $5.35, exceeding analyst expectations, with a revenue increase of 9.6% year-over-year.
• Investment analysts have varying ratings on UHS, with a consensus Hold rating and a price target of approximately $218.69.

Universal Health Services, Inc. (NYSE:UHS - Free Report) - Research analysts at Leerink Partnrs raised their Q3 2025 earnings estimates for shares of Universal Health Services in a research note issued to investors on Wednesday, October 22nd. Leerink Partnrs analyst W. Mayo now forecasts that the health services provider will earn $4.88 per share for the quarter, up from their previous estimate of $4.17. The consensus estimate for Universal Health Services' current full-year earnings is $15.92 per share. Leerink Partnrs also issued estimates for Universal Health Services' FY2025 earnings at $21.33 EPS, Q1 2026 earnings at $5.02 EPS, Q3 2026 earnings at $5.38 EPS, FY2026 earnings at $22.90 EPS, FY2027 earnings at $25.19 EPS, FY2028 earnings at $27.63 EPS and FY2029 earnings at $30.24 EPS.

Universal Health Services (NYSE:UHS - Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The health services provider reported $5.35 EPS for the quarter, topping analysts' consensus estimates of $4.85 by $0.50. The business had revenue of $4.28 billion for the quarter, compared to analysts' expectations of $4.24 billion. Universal Health Services had a net margin of 7.66% and a return on equity of 18.25%. The business's revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $4.31 EPS. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS.

A number of other equities research analysts have also recently commented on the stock. Royal Bank Of Canada raised their price objective on shares of Universal Health Services from $201.00 to $206.00 and gave the stock a "sector perform" rating in a research note on Tuesday, August 19th. The Goldman Sachs Group started coverage on shares of Universal Health Services in a research note on Tuesday, October 14th. They set a "neutral" rating and a $219.00 price objective on the stock. Barclays dropped their price objective on shares of Universal Health Services from $259.00 to $250.00 and set an "overweight" rating on the stock in a research note on Thursday, September 18th. Wall Street Zen raised shares of Universal Health Services from a "buy" rating to a "strong-buy" rating in a research note on Saturday, October 11th. Finally, Wells Fargo & Company increased their target price on Universal Health Services from $210.00 to $249.00 and gave the company an "overweight" rating in a research report on Tuesday, October 7th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $218.69.

Universal Health Services Price Performance

Shares of NYSE UHS opened at $208.59 on Friday. The stock has a market capitalization of $13.27 billion, a price-to-earnings ratio of 10.98, a PEG ratio of 0.87 and a beta of 1.30. Universal Health Services has a 12 month low of $152.33 and a 12 month high of $234.39. The firm's 50 day simple moving average is $193.64 and its 200-day simple moving average is $183.14. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.29 and a quick ratio of 1.19.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Invesco Ltd. lifted its position in shares of Universal Health Services by 11.1% during the 2nd quarter. Invesco Ltd. now owns 1,461,198 shares of the health services provider's stock valued at $264,696,000 after buying an additional 145,730 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Universal Health Services by 9.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,241,738 shares of the health services provider's stock valued at $233,311,000 after purchasing an additional 102,137 shares in the last quarter. AQR Capital Management LLC lifted its holdings in Universal Health Services by 57.8% in the 1st quarter. AQR Capital Management LLC now owns 931,355 shares of the health services provider's stock valued at $173,381,000 after purchasing an additional 340,966 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Universal Health Services by 3.5% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 926,669 shares of the health services provider's stock valued at $167,866,000 after purchasing an additional 31,201 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in Universal Health Services by 0.8% in the 2nd quarter. American Century Companies Inc. now owns 639,524 shares of the health services provider's stock valued at $115,850,000 after purchasing an additional 4,932 shares in the last quarter. Hedge funds and other institutional investors own 86.05% of the company's stock.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.